Replies to post #16694 on Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Grill....I guess the part I dont get is as you say, the NDA filing is what people are waiting for to validate the company. why? they have already successfully filed and received two ANDA's. while relatively low on revenue because of competition and other factors like lask of full approval on all dosages, and of course keppra is a low value drug to begin with, its the fact that does validate their technology and their ability to successfully negotiate the FDA. I see no difference then in merely filing an NDA. at that point if that is what the street is waiting for to validate the company then we probably wont see any real movement until after an approval. again, based on what Angelo provided, at this point they should have a 90% success rate of being approved, and that should be factored in.